Nurse Practitioner · Wausau, WI
NPI
1982071270
Since 2015
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
425 Pine Ridge Blvd, Suite220a
Wausau, WI, 54401
Phone (715) 847-2070
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
667 services
Medicare patients, 2024
150
Average age 71
Drug cost, 2024
$1.3M
2,994 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wendy J Mattlin was code 99214 (office e&m - established), 257 times for 133 patients. In total Wendy J Mattlin billed 667 services in 12 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 257 | 133 | $70.65 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 181 | 113 | $9.30 | $1,683 |
| 95251 Test - Miscellaneous | Office | 127 | 44 | $21.59 | $2,742 |
| 99213 Office E&M - Established | Office | 16 | 15 | $43.70 | $699 |
By year: 2022 $25K for 416 services; 2023 $22K for 383 services; 2024 $27K for 667 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wendy J Mattlin prescribed most often to Medicare patients was Levothyroxine Sodium, with 209 prescriptions and refills. In total Wendy J Mattlin wrote 2,994 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 209 | 542 | 59 | $1,898 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 207 | 516 | 66 | $41K |
| Trulicity Dulaglutide | 199 | 257 | 37 | $247K |
| Metformin Hcl Er Metformin Hcl | 166 | 428 | 54 | $2,079 |
| Metformin Hcl Generic | 140 | 398 | 45 | $947 |
| Ozempic Semaglutide | 135 | 194 | 26 | $182K |
| Methimazole Generic | 117 | 282 | 33 | $1,091 |
| Jardiance Empagliflozin | 107 | 231 | 32 | $131K |
| Novolog Flexpen Insulin Aspart | 88 | 178 | 29 | $32K |
| Glipizide Er Glipizide | 82 | 237 | 22 | $1,905 |
| Semglee (Yfgn) Pen Insulin Glargine-Yfgn | 77 | 199 | 23 | $61K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 57 | 126 | 17 | $46K |
| Mounjaro Tirzepatide | 57 | 70 | 13 | $76K |
| Humalog Kwikpen U-100 Insulin Lispro | 55 | 141 | 23 | $26K |
| Synthroid Levothyroxine Sodium | 53 | 139 | 15 | $5,437 |
Brand drugs: 1,696 claims; generic drugs: 980 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Wendy J Mattlin were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.